# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 2712 results.
Imaging Study in Advanced Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 18, 2019
First Received: Jan 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Ultrasound, CT and WB-DWI/MRI
Locations: Gynecologic Oncology Center in Prague, Prague, Czechia
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families
Status: Recruiting
Last Changed: May 13, 2020
First Received: Apr 18, 2017
Disease(s): Ovarian Cancer
Locations: University of Washington, Seattle, Washington, United States
p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer
Status: Completed
Last Changed: Feb 25, 2011
First Received: Feb 16, 2009
Disease(s): Ovarian Cancer
Intervention(s): P53-SLP vaccine, Cyclophosphamide
Locations: University Medical Centre Groningen, Groningen, Netherlands
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
Status: Not yet recruiting
Last Changed: Aug 02, 2018
First Received: Aug 02, 2018
Disease(s): Advanced Ovarian Cancer
Intervention(s): Bevacizumab
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Completed
Last Changed: Aug 12, 2020
First Received: Mar 20, 2014
Disease(s): Ovarian Cancer
Intervention(s): OMP-54F28, Paclitaxel and Carboplatin
Locations: Memorial Sloan Kettering Cancer Center, New York, New York, United States
OU Medical Center Laboratory, Oklahoma City, Oklahoma, United States
The University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
Fox-Chase Cancer Center, Philadelphia, Pennsylvania, United States
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
Status: Active, not recruiting
Last Changed: Jun 30, 2020
First Received: Nov 20, 2015
Disease(s): Ovarian Cancer
Intervention(s): Pembrolizumab, Gemcitabine, Cisplatin
Locations: Cedars-Sinai Medical Center, Los Angeles, California, United States
Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Status: Unknown status
Last Changed: Oct 06, 2016
First Received: Jun 28, 2013
Disease(s): Ovarian Cancer
Intervention(s): PET/CT(3hours]
Locations: Department of Nuclear Medicine, Odense C, Fünen, Denmark
Living Well: A Web-Based Program for Ovarian Cancer Survivors
Status: Not yet recruiting
Last Changed: Sep 01, 2020
First Received: Sep 01, 2020
Disease(s): Ovarian Cancer
Intervention(s): Technology-based Mindful Living program, Technology-based Healthy Lifestyles program
Locations: University of Miami, Miami, Florida, United States
University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States
University of Washington, Seattle, Washington, United States
Hydralazine Valproate for Ovarian Cancer
Status: Unknown status
Last Changed: Sep 21, 2007
First Received: Sep 21, 2007
Disease(s): Ovarian Cancer
Intervention(s): Hydralazine and magnesium valproate, Placebo
Locations: Instituto Nacional de Cancerologia, Mexico City, Tlalpan, Mexico
Blood Test for Ovarian Cancer Associated Auto Antibodies
Status: Unknown status
Last Changed: Feb 20, 2014
First Received: Apr 13, 2011
Disease(s): Ovarian Cancer
Locations: "Carmel" Medical Center, Haifa, Israel